Zinc supplementation decreases incidence of infections in the elderly: effect of zinc on generation of cytokines and oxidative stress
Open accessAbstract
Background Zinc deficiency, cell-mediated immune dysfunction, susceptibility to infections, and increased oxidative stress have been observed in elderly subjects (ie, those >55 y old). Zinc is an effective antiinflammatory and antioxidant agent.Objectives The primary objective was to determine the effect of zinc on the incidence of total infections in healthy elderly subjects. The secondary objective was to determine the effect of zinc on cytokines and oxidative stress markers.Design A randomized, double-blind, placebo-controlled trial of zinc supplementation was conducted in elderly subjects. Fifty healthy subjects of both sexes aged 55-87 y and inclusive of all ethnic groups were recruited for this study from a senior center. The zinc-supplemented group received zinc gluconate (45 mg elemental Zn/d) orally for 12 mo. Incidence of infections during the supplementation period was documented. The generation of inflammatory cytokines, T helper 1 and T helper 2 cytokines, and oxidative stress markers and the plasma concentrations of zinc were measured at baseline and after supplementation.Results Compared with a group of younger adults, at baseline the older subjects had significantly lower plasma zinc, higher ex vivo generation of inflammatory cytokines and interleukin 10, and higher plasma oxidative stress markers and endothelial cell adhesion molecules. The incidence of infections and ex vivo generation of tumor necrosis factor alpha and plasma oxidative stress markers were significantly lower in the zinc-supplemented than in the placebo group. Plasma zinc and phytohemagglutin-induced interleukin 2 mRNA in isolated mononuclear cells were significantly higher in the zinc-supplemented than in the placebo group.Conclusions After zinc supplementation, the incidence of infections was significantly lower, plasma zinc was significantly higher, and generation of tumor necrosis factor alpha and oxidative stress markers was significantly lower in the zinc-supplemented than in the placebo group.
AI snapshot
Written from the paper’s full text.
TL;DR
In a 12-month randomized, double-blind, placebo-controlled trial, daily zinc gluconate (45 mg elemental zinc) lowered infection incidence and reduced ex vivo TNF-α and plasma oxidative stress markers in healthy older adults. Zinc also raised plasma zinc and PHA-induced IL-2 mRNA in zinc-deficient elderly participants.
Key findings
- Infection incidence over 12 months was lower with zinc than placebo: 0.29 ± 0.46 vs 1.4 ± 0.95 infections per subject (P < 0.01; effect size 1.46); 29% vs 88% of subjects affected (P = 0.001), and 17 zinc recipients vs 3 placebo recipients had no infection.
- Plasma zinc rose in the zinc group (92.9 ± 9.45 to 104 ± 16.69 µg/dL at 12 mo) while the placebo group trended down (95.7 ± 13.09 to 88.5 ± 9.66; P = 0.0002).
- Ex vivo TNF-α generation fell significantly in the zinc group and rose in the placebo group, with maximal reduction at 6 mo; oxidative stress markers also improved: MDA+HAE 1.66 ± 0.34 to 1.35 ± 0.18 vs 1.70 ± 0.30 to 1.71 ± 0.35 µmol/L (P = 0.0002), and 8-OHdG 0.63 ± 0.16 to 0.50 ± 0.14 vs 0.66 ± 0.13 to 0.68 ± 0.13 ng/mL (P = 0.030).
- In a separate 6-month substudy of zinc-deficient elderly, PHA-induced IL-2 mRNA increased with zinc (0.38 ± 0.07 to 0.63 ± 0.03) but not placebo (0.40 ± 0.05 to 0.39 ± 0.04; P = 0.001); plasma zinc also increased (84.0 ± 3.03 to 97.6 ± 5.98 vs 86.8 ± 2.04 to 89.2 ± 3.06 µg/dL; P = 0.0088).
Methods
- Randomized, double-blind, placebo-controlled 12-month trial in 50 healthy elderly adults aged 55–87 recruited from a senior center; one zinc-group participant dropped out on day 2, leaving complete data for 49 (tables report 24 zinc, 25 placebo). The zinc group received 45 mg elemental zinc/d as zinc gluconate; the primary endpoint was infection incidence, with secondary cytokine and oxidative stress measures.
- Baseline comparisons were made with 31 younger adults aged 18–54 for plasma zinc, adhesion molecules, nitric oxide, MDA, and ex vivo inflammatory cytokines.
- A separate substudy randomized 12 zinc-deficient elderly subjects to zinc or placebo for 6 months to measure plasma zinc and PHA-stimulated IL-2 mRNA by RT-PCR in mononuclear cells; analyses used t tests, Wilcoxon rank-sum, chi-square/Fisher exact, paired t tests, and multivariate repeated-measures models.
Limitations
- The authors state that the trial’s main limitation was its small number of subjects and call for larger zinc trials in the elderly.
- Evident from the text: the IL-2 mRNA substudy had only 6 subjects per group, and oxidative stress markers were measured at 6 months but not repeated at 12 months.
- Evident from the text: participants came from one senior center and were described as healthier than nursing-home residents, which may limit generalizability; some baseline imbalances were noted (higher IL-10 in the zinc group; lower plasma zinc in the zinc substudy group despite randomization).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 67 cited sources checked · 0 supported · 0 flagged
- Findingown data
In zinc-supplemented elderly, 17 subjects had no evidence of any infection during study, versus 3 in placebo.
“Seventeen subjects in the zinc-supplemented group had no evidence of any infection during the study, but only 3 subjects in the placebo group had no evidence of infection.”
Quote in the paperSubstantial claim - Findingown data
Ex vivo generation of TNF-α increased significantly over 12 months in placebo elderly.
“Also with time (12 mo of supplementation), the ex vivo generation of TNF-␣ decreased significantly in the zincsupplemented subjects and increased significantly in the placebo group (Table 5).”
Quote in the paperSubstantial claim - Findingown data
Baseline IL-10 generation by Th2 cells was significantly higher in healthy elderly than in younger adults.
“Compared with a group of younger adults, at baseline the older subjects had significantly lower plasma zinc, higher ex vivo generation of inflammatory cytokines and interleukin 10, and higher plasma oxidative stress markers and endothelial cell adhesion molecules.”
- Also stated in: § RESULTS · plain
“IL-10 generated by Th2 cells, which are known to produce a negative effect on IL-2 generated by Th1 cells) was significantly higher in the elderly.”
Quote in the paperNot a substantial claim - Also stated in: § RESULTS · plain
- Findingown data
In zinc-supplemented elderly, total incidence of infections over 12 months was 7, versus 35 in placebo.
“In the zinc-supplemented group, the total incidence of infections was 7 (2 from January through March, 0 from April through June, 3 from July through September, and 2 from October through December).In the placebo group, the total incidence of infections was 35 (8 from January through March, 11 from April through June, 7 from July through September, and 9 from October through December).”
Quote in the paperSubstantial claim - Findingown data
Zinc supplementation for 12 months significantly reduced mean incidence of infections per subject compared with placebo in healthy elderly.
“The incidence of infections and ex vivo generation of tumor necrosis factor ␣ and plasma oxidative stress markers were significantly lower in the zinc-supplemented than in the placebo group.”
- Also stated in: § RESULTS · plain
“The mean incidence of infections per subject in 12 mo was significantly (P 0.01) lower in the zinc-supplemented group (0.29 Ȁ 0.46) than in the placebo group (1.4 Ȁ 0.95; effect size: 1.46).”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
At baseline, zinc-deficient elderly had lower plasma zinc concentration than zinc-sufficient elderly (85.4 vs 94.5 μg/dL, P=0.0001).
“Their mean plasma zinc concentration at baseline was 94.5 Ȁ 2.54 g/dL, whereas that in the 12 zinc-deficient subjects was 85.4 Ȁ 2.54 g/dL (P ҃ 0.0001).”
Quote in the paperNot a substantial claim - Findingown data
Baseline plasma endothelial cell adhesion molecules (intercellular adhesion molecule, vascular endothelial cell adhesion molecule, E-selectin) were significantly higher in healthy elderly than in younger adults.
“Compared with a group of younger adults, at baseline the older subjects had significantly lower plasma zinc, higher ex vivo generation of inflammatory cytokines and interleukin 10, and higher plasma oxidative stress markers and endothelial cell adhesion molecules.”
- Also stated in: § RESULTS · plain
“Intercellular adhesion molecules, vascular endothelial cell adhesion molecules, and E-selectin in the plasma also were significantly higher in the elderly.”
Quote in the paperNot a substantial claim - Also stated in: § RESULTS · plain
- Findingown data
Changes in plasma oxidative stress markers (MDA+HAE and 8-oHdG) from baseline to 6 months showed a greater significant decrease in zinc-supplemented than placebo elderly.
“The changes in concentrations of plasma molecular markers of oxidative stress (MDA ѿ HAE and 8-oHdG) between baseline and at the end of 6 mo of zinc supplementation showed a greater (and significant) decrease in the zinc-supplemented group than in the placebo group (Table 6).”
- Also stated in: § Abstract · plain
“The incidence of infections and ex vivo generation of tumor necrosis factor ␣ and plasma oxidative stress markers were significantly lower in the zinc-supplemented than in the placebo group.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
Baseline plasma zinc was significantly lower in healthy elderly than in younger adults.
“Compared with a group of younger adults, at baseline the older subjects had significantly lower plasma zinc, higher ex vivo generation of inflammatory cytokines and interleukin 10, and higher plasma oxidative stress markers and endothelial cell adhesion molecules.”
- Also stated in: § RESULTS · plain
“Plasma zinc was lower and the percentage of cells producing IL-1 and TNF-␣ and the generated concentrations of these cytokines were significantly higher in the elderly subjects.”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
At baseline, zinc-deficient elderly had lower IL-2 mRNA than zinc-sufficient elderly (0.39 vs 0.59, P=0.0001).
“At baseline, the IL-2 mRNA of the zinc-sufficient subjects was 0.59 Ȁ 0.05 and that of the zinc-deficient subjects was 0.39 Ȁ 0.06 (P ҃ 0.0001).”
Quote in the paperNot a substantial claim - Findingown data
Baseline plasma oxidative stress markers were significantly higher in healthy elderly than in younger adults.
“Compared with a group of younger adults, at baseline the older subjects had significantly lower plasma zinc, higher ex vivo generation of inflammatory cytokines and interleukin 10, and higher plasma oxidative stress markers and endothelial cell adhesion molecules.”
- Also stated in: § RESULTS · plain
“The oxidative stress markers also were significantly higher in the elderly than in the younger adults.”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
Plasma zinc concentration trended lower over 12 months in placebo elderly.
“With time (12 mo of supplementation), the plasma zinc concentration in the subjects in the zinc group increased significantly, whereas that in the placebo group trended lower (Table 4).”
Quote in the paperNot a substantial claim - Findingown data
Percentage of cells positive for TNF-α, IL-1β, or IL-10 did not change significantly with time in either placebo or zinc-supplemented elderly.
“The percentage of cells positive for TNF-␣, IL-1, or IL-10 did not change significantly with time in either the placebo or zincsupplemented group.”
Quote in the paperNot a substantial claim - Findingown data
PHA-induced IL-2 mRNA in isolated mononuclear cells was significantly higher in zinc-supplemented than placebo elderly.
“Plasma zinc and phytohemagglutin-induced interleukin 2 mRNA in isolated mononuclear cells were significantly higher in the zincsupplemented than in the placebo group.”
Quote in the paperNot a substantial claim - Findingown data
In a preliminary study, mean incidence of infections was 1.4 ± 0.95 per year in 24 zinc-nonsupplemented elderly subjects.
“With the use of the definition for infection as outlined above, the mean (ȀSD) incidence of infections was 1.4 Ȁ 0.95/y in each of 24 zinc-nonsupplemented elderly subjects.”
Quote in the paperSubstantial claim - Findingown data
Ex vivo generation of TNF-α decreased significantly over 12 months in zinc-supplemented elderly.
“Also with time (12 mo of supplementation), the ex vivo generation of TNF-␣ decreased significantly in the zincsupplemented subjects and increased significantly in the placebo group (Table 5).”
- Also stated in: § Abstract · plain
“The incidence of infections and ex vivo generation of tumor necrosis factor ␣ and plasma oxidative stress markers were significantly lower in the zinc-supplemented than in the placebo group.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
Baseline ex vivo generation of inflammatory cytokines was significantly higher in healthy elderly than in younger adults.
“Compared with a group of younger adults, at baseline the older subjects had significantly lower plasma zinc, higher ex vivo generation of inflammatory cytokines and interleukin 10, and higher plasma oxidative stress markers and endothelial cell adhesion molecules.”
- Also stated in: § RESULTS · plain
“Plasma zinc was lower and the percentage of cells producing IL-1 and TNF-␣ and the generated concentrations of these cytokines were significantly higher in the elderly subjects.”
Quote in the paperSubstantial claim - Also stated in: § RESULTS · plain
- Findingown data
Plasma zinc concentration increased significantly over 12 months in zinc-supplemented elderly.
“With time (12 mo of supplementation), the plasma zinc concentration in the subjects in the zinc group increased significantly, whereas that in the placebo group trended lower (Table 4).”
- Also stated in: § Abstract · plain
“Plasma zinc and phytohemagglutin-induced interleukin 2 mRNA in isolated mononuclear cells were significantly higher in the zincsupplemented than in the placebo group.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
The reduction in TNF-α concentration was maximal at the end of 6 months.
“The reduction in TNF-␣ concentration was maximal at the end of 6 mo.”
Quote in the paperNot a substantial claim - Findingown data
At baseline, there was no significant difference between groups in the percentage of cells positive for IL-1β.
“No significant differences (t test) were found in the percentage of cells positive for TNF-␣, IL-1, or IL-10 or in generated TNF-␣ and IL-1 between the 2 groups at baseline.”
Quote in the paperNot a substantial claim - Findingown data
In zinc-deficient elderly subjects, zinc supplementation raised ex vivo PHA-stimulated IL-2 mRNA expression in mononuclear cells relative to placebo.
“In MNCs isolated from zinc-deficient elderly subjects, zinc supplementation increased the ex vivo PHA-induced IL-2 mRNA expression and plasma zinc concentration above the values found in the zinc-deficient subjects who were given placebo (P 0.05; Table 7).”
Quote in the paperSubstantial claim - Findingown data
In the placebo-treated group, IL-2 mRNA did not change over the 6-month period.
“In the zinc-supplemented group, both of these variables increased during the 6-mo period, whereas they did not change in the placebo-treated group (Table 7).”
Quote in the paperNot a substantial claim - Findingown data
At baseline, there was no significant difference between groups in the percentage of cells positive for IL-10.
“No significant differences (t test) were found in the percentage of cells positive for TNF-␣, IL-1, or IL-10 or in generated TNF-␣ and IL-1 between the 2 groups at baseline.”
Quote in the paperNot a substantial claim - Findingown data
At baseline, IL-2 mRNA concentration did not differ significantly between the zinc and placebo groups.
“At baseline, the plasma zinc and IL-2 mRNA concentrations did not differ significantly between the zinc and placebo group subjects (Table 7).”
- Also stated in: § DISCUSSION · plain
“No significant difference (t test) in IL-2 mRNA was found between the 2 groups at baseline.”
Quote in the paperNot a substantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
At baseline, there was no significant difference between groups in generated TNF-α.
“No significant differences (t test) were found in the percentage of cells positive for TNF-␣, IL-1, or IL-10 or in generated TNF-␣ and IL-1 between the 2 groups at baseline.”
Quote in the paperNot a substantial claim - Findingown data
At baseline, no significant differences in oxidative stress markers were found between the zinc and placebo groups.
“No significant differences (t test) in oxidative stress markers were found between the 2 groups at baseline.”
Quote in the paperNot a substantial claim - Findingown data
Over time, TNF-α changed significantly from baseline in both the zinc and placebo groups.
“The repeated measures by group (zinc and placebo) for TNF-␣ showed a significant change (P ҃ 0.012 and 0.042, respectively), which means that, over time, TNF-␣ changed from baseline in both groups.”
Quote in the paperNot a substantial claim - Findingown data
At baseline, there was no significant difference between the zinc and placebo groups in the percentage of cells positive for TNF-α.
“No significant differences (t test) were found in the percentage of cells positive for TNF-␣, IL-1, or IL-10 or in generated TNF-␣ and IL-1 between the 2 groups at baseline.”
Quote in the paperNot a substantial claim - Findingown data
During the 6-month observation period, two subjects in the zinc-treated group each had one episode of bronchitis.
“During the 6-mo observation period, 2 subjects in the zinc-treated group had one episode of bronchitis each.”
Quote in the paperNot a substantial claim - Findingown data
Zinc supplementation decreased concentrations of oxidative stress markers in subjects who were not zinc deficient at baseline.
“We observed, however, that zinc supplementation also decreased concentrations of oxidative stress markers and showed antiinflammatory responses in subjects who were not zinc deficient as judged by plasma zinc concentrations at baseline, which suggested that zinc had a therapeutic effect in this regard similar to the effect we had earlier reported in healthy volunteers (19).”
Quote in the paperNot a substantial claim - Findingown data
In the elderly, zinc supplementation significantly decreased the incidence of infection compared with placebo (29% vs 88% affected, P=0.001).
“Our study showed that zinc supplementation administered to the elderly population resulted in a significant decrease in the incidence of infection.”
- Also stated in: § DISCUSSION · plain
“| Infection | 29 | 88 | 0.001 |”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
In zinc-deficient elderly subjects, zinc supplementation raised plasma zinc concentration relative to placebo.
“In MNCs isolated from zinc-deficient elderly subjects, zinc supplementation increased the ex vivo PHA-induced IL-2 mRNA expression and plasma zinc concentration above the values found in the zinc-deficient subjects who were given placebo (P 0.05; Table 7).”
Quote in the paperSubstantial claim - Findingown data
There was a significant group-by-time interaction for plasma zinc concentration.
“Group ҂ time interactions were significant for IL-2 mRNA (P ҃ 0.0001) and plasma zinc (P ҃ 0.0088) concentrations.”
Quote in the paperSubstantial claim - Findingown data
At baseline, plasma zinc concentration did not differ significantly between the zinc and placebo groups.
“At baseline, the plasma zinc and IL-2 mRNA concentrations did not differ significantly between the zinc and placebo group subjects (Table 7).”
Quote in the paperSubstantial claim - Findingown data
At baseline, there was no significant difference between groups in generated IL-1β.
“No significant differences (t test) were found in the percentage of cells positive for TNF-␣, IL-1, or IL-10 or in generated TNF-␣ and IL-1 between the 2 groups at baseline.”
Quote in the paperNot a substantial claim - Findingown data
According to the study's plasma zinc criteria, about 35% of the elderly subjects in the current study were zinc-deficient.
“According to our plasma zinc criteria, Ȃ35% of the elderly subjects in the current study were considered zinc-deficient.”
Quote in the paperSubstantial claim- Rests on an assumption: The plasma zinc criteria used by the authors validly classify elderly subjects as zinc-deficient.
- Findingown data
In the placebo-treated group, plasma zinc did not change over the 6-month period.
“In the zinc-supplemented group, both of these variables increased during the 6-mo period, whereas they did not change in the placebo-treated group (Table 7).”
Quote in the paperNot a substantial claim - Findingown data
In the zinc-supplemented group, IL-2 mRNA increased over the 6-month period.
“In the zinc-supplemented group, both of these variables increased during the 6-mo period, whereas they did not change in the placebo-treated group (Table 7).”
Quote in the paperSubstantial claim - Findingown data
There was a significant group-by-time interaction for IL-2 mRNA concentration.
“Group ҂ time interactions were significant for IL-2 mRNA (P ҃ 0.0001) and plasma zinc (P ҃ 0.0088) concentrations.”
Quote in the paperSubstantial claim - Findingown data
In the zinc-supplemented group, plasma zinc increased over the 6-month period.
“In the zinc-supplemented group, both of these variables increased during the 6-mo period, whereas they did not change in the placebo-treated group (Table 7).”
Quote in the paperNot a substantial claim - Findingown data
During the 6-month observation period, four subjects in the placebo-treated group had an infection (one each with laryngitis, flu, URI, and common cold).
“In the placebo-treated group, 4 subjects had an infection: 1 subject each had laryngitis, flu, URI, and common cold.”
Quote in the paperSubstantial claim - Findingcitation
Zinc supplementation decreased production of inflammatory cytokines.
“Zinc supplementation decreased not only the production of inflammatory cytokines but also that of oxidative stress markers, as we previously reported (19,29).”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
Zinc supplementation showed antiinflammatory responses in subjects who were not zinc deficient at baseline.
“We observed, however, that zinc supplementation also decreased concentrations of oxidative stress markers and showed antiinflammatory responses in subjects who were not zinc deficient as judged by plasma zinc concentrations at baseline, which suggested that zinc had a therapeutic effect in this regard similar to the effect we had earlier reported in healthy volunteers (19).”
Quote in the paperNot a substantial claim - Findingcitation
Zinc supplementation decreased oxidative stress markers.
“Zinc supplementation decreased not only the production of inflammatory cytokines but also that of oxidative stress markers, as we previously reported (19,29).”
Quote in the paperSubstantial claim0 of 2 sources checked - Findingown data
Zinc supplementation decreased IL-10 production in elderly subjects.
“We have also observed a decrease in IL-10 production in zinc-supplemented elderly subjects, and this decrease may also have an effect of increasing IL-2 production (40).”
Quote in the paperNot a substantial claim - Findingown data
Administration of 45 mg elemental zinc/d did not reduce plasma copper concentrations in zinc-supplemented elderly subjects.
“The administration of 45 mg elemental zinc/d did not reduce plasma copper concentrations in zinc-supplemented elderly subjects.”
Quote in the paperNot a substantial claim - Findingown data
Ex vivo generation of TNF-α from isolated MNCs is significantly decreased in elderly subjects after zinc supplementation.
“Most important, we show here that the ex vivo generation of TNF-␣ from isolated MNCs is significantly decreased in elderly subjects after zinc supplementation.”
Quote in the paperSubstantial claim - Findingown data
In the placebo group, TNF-α increased with time.
“We also observed in the placebo group that TNF-␣ increased with time, which suggests that this increase may be an effect of increasing age.”
Quote in the paperNot a substantial claim - Findingown data
Elderly subjects are oxidatively stressed.
“Results from the current study show that elderly subjects are oxidatively stressed and that zinc is an effective antiinflammatory as well as an antioxidant agent.”
Quote in the paperSubstantial claim - Premisecitation
Zinc intake from diet falls as people age in both developed and developing nations.
“Dietary zinc intake declines with advancing age in both developing and developed countries (3,4).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] Cakman, 1997, Zinc supplementation reconstitutes the production of interferon-α by leukocytes from elderly persons, J Interferon Cytokine Res source
Not checked in the free run.
- cites [4] Prasad, 1993
Not checked in the free run.
- Premisecitation
Cell-culture and animal studies show that zinc has several antioxidant actions.
“Multiple roles of zinc as an antioxidant in cell cultures and animal models have been observed (5)(6)(7)(8).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [5] Castro, 2001, Reactive oxygen species in human health and disease, Nutrition source
Not checked in the free run.
- cites [6] Davis, 2001, Soy isoflavone supplementation in healthy men prevents NF-κB activation by TNF-α in blood lymphocytes, Free Rad Biol Med source
Not checked in the free run.
- cites [7] Lachance, 2001, Antioxidants: an integrative approach, Nutrition source
Not checked in the free run.
- Premisecitation
Inflammatory cytokines TNF-α and IL-1β, generated by activated monocytes and macrophages, generate greater amounts of reactive oxygen species.
“Inflammatory cytokines such as tumor necrosis factor ␣ (TNF-␣) and interleukin (IL) 1, generated by activated monocytes and macrophages, are also known to generate greater amounts of reactive oxygen species (9,10).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [9] Ozaki, 1987, Potentiation of neutrophil function by recombinant DNA-produced interleukin-1α, J Leukocyte Biol source
Not checked in the free run.
- cites [10] Berkow, 1987, Enhancement of neutrophil superoxide production by pre-incubation with recombinant human tumor necrosis factor, J Immunol source
Not checked in the free run.
- Premisecitation
In those adults, zinc supplements protected isolated mononuclear cells from TNF-α-induced NF-κB activation.
“and provided protection against TNF-␣-induced nuclear factor- activation in isolated MNCs (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Prasad, 2004, Anti-oxidant effect of zinc in humans, Free Rad Biol Med source
Not checked in the free run.
- Premisecitation
In healthy 20-50-year-old adults, zinc supplements lowered plasma levels of MDA, HAE, and 8-hydroxydeoxyguanine.
“Zinc supplementation to healthy human subjects aged 20 -50 y reduced the concentrations of the oxidative stress-related byproducts malondialdehyde (MDA), 4-hydroxyalkenals (HAE), and 8-hydroxydeoxyguanine in the plasma;”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Prasad, 2004, Anti-oxidant effect of zinc in humans, Free Rad Biol Med source
Not checked in the free run.
- Premisecitation
In those adults, zinc supplements blocked ex vivo induction of TNF-α and IL-1β mRNA in mononuclear cells.
“inhibited the ex vivo induction of TNF-␣ and IL-1 mRNA in mononuclear cells (MNCs);”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Prasad, 2004, Anti-oxidant effect of zinc in humans, Free Rad Biol Med source
Not checked in the free run.
- Study design and conductown data
Despite random assignment, plasma zinc concentration was significantly lower in the zinc group than in the placebo group at baseline (P=0.016).
“Despite the random assignment of zinc-deficient subjects into zinc or placebo group, the plasma zinc concentration was significantly lower in the zinc group than in the placebo group (P ҃ 0.016).”
Quote in the paperNot a substantial claim - Premisecitation
Animal studies show that zinc deficiency decreases resistance to bacterial, viral, fungal, and parasitic pathogens.
“Many animal studies show that zinc deficiency decreases resistance to a range of bacterial, viral, fungal, and parasitic pathogens (29), probably because of the immune impairment induced by zinc deficiency.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Shankar, 1998, Zinc and immune function: the biological basis of altered resistance to infection, Am J Clin Nutr source
Not checked in the free run.
- Interpretationcitation
The decreased resistance to pathogens in zinc deficiency is probably due to immune impairment induced by zinc deficiency.
“Many animal studies show that zinc deficiency decreases resistance to a range of bacterial, viral, fungal, and parasitic pathogens (29), probably because of the immune impairment induced by zinc deficiency.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] Shankar, 1998, Zinc and immune function: the biological basis of altered resistance to infection, Am J Clin Nutr source
Not checked in the free run.
- Interpretationown data
Plasma zinc concentrations in the elderly subjects were low, suggesting marginal zinc deficiency in this group.
“zinc concentrations in our elderly subjects were low, which suggested that a marginal zinc deficiency was present in this group.”
Quote in the paperSubstantial claim - Premisecitation
Zinc deficiency adversely affects production of IL-2 and IFN-γ.
“Zinc deficiency not only adversely affects the production of IL-2 and IFN-␥ but also decreases the IL-12 production from macrophages (AS Prasad, personal observations, 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites AS Prasad, personal observations, 2002
Not checked in the free run.
- Interpretationown data
Zinc had a therapeutic effect in subjects not zinc deficient at baseline similar to that previously reported in healthy volunteers.
“We observed, however, that zinc supplementation also decreased concentrations of oxidative stress markers and showed antiinflammatory responses in subjects who were not zinc deficient as judged by plasma zinc concentrations at baseline, which suggested that zinc had a therapeutic effect in this regard similar to the effect we had earlier reported in healthy volunteers (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Prasad, 2004, Anti-oxidant effect of zinc in humans, Free Rad Biol Med source
Not checked in the free run.
- Premisecitation
Schistosoma mansoni egg counts in children given zinc supplements were lower than in children who received placebo.
“Schistosoma mansoni egg counts observed in children given zinc supplements were lower than those in children who received placebo (33).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Friis, 1997, The effect of zinc supplementation on Schistosoma mansonireinfection rate and intensities: a randomized, controlled trial among rural Zimbabwean school children, Eur J Clin Nutr source
Not checked in the free run.
- Premisecitation
Acrodermatitis enteropathica patients have fewer infections when given supranormal amounts of zinc supplementation.
“In addition, Acrodermatitis enteropathica patients have fewer infections when given supranormal amounts of zinc supplementation (4).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [4] Prasad, 1993
Not checked in the free run.
- Interpretationown data
Zinc deficiency may activate monocytes and macrophages to generate inflammatory cytokines.
“We previously observed that, in zinc-deficient persons, ex vivo generation of IL-1 is increased, which suggests that zinc deficiency, per se, may activate monocytes and macrophages to generate inflammatory cytokines.”
Quote in the paperSubstantial claim - Premisecitation
Numerous studies have shown benefits of zinc supplementation for infectious diseases in human populations.
“Numerous studies have shown the benefits of zinc supplementation with respect to infectious diseases in human populations (29).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [29] Shankar, 1998, Zinc and immune function: the biological basis of altered resistance to infection, Am J Clin Nutr source
Not checked in the free run.
- Premisecitation
IL-2 production in zinc-deficient patients with sickle cell disease was low.
“IL-2 production in zinc-deficient patients with sickle cell disease was low, and oral zinc supplementation (75 mg zinc as acetate) resulted in a decreased incidence of infections, fewer days in the hospitals, and correction of ex vivo IL-2 generation (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Prasad, 1999, Effects of zinc supplemntation on incidence of infections and hospital admissions in sickle cell disease (SCD), Am J Hematol source
Not checked in the free run.
- Premisecitation
Controlled trials of zinc supplementation in infants and children showed a reduction of up to 50% in incidence of pneumonia.
“Controlled trials of zinc supplementation in infants and children showed a 25-30% reduction in the incidence and duration of acute and chronic diarrhea and a reduction of up to 50% in the incidence of pneumonia (30 -32).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [30] Sazawal, 1995, Zinc supplementation in young children with acute diarrhea in India, N Engl J Med source
Not checked in the free run.
- cites [31] Sazawal, 1996, Zinc supplementation reduces the incidence of persistent diarrhea and dysentery among low socioeconomic children in India, J Nutr source
Not checked in the free run.
- cites [32] Sazawal, 1998, Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children—a double-blind controlled trial, Pediatrics source
Not checked in the free run.
- Premisecitation
Zinc deficiency decreases IL-12 production from macrophages.
“Zinc deficiency not only adversely affects the production of IL-2 and IFN-␥ but also decreases the IL-12 production from macrophages (AS Prasad, personal observations, 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites AS Prasad, personal observations, 2002
Not checked in the free run.
- Premisecitation
Controlled trials of zinc supplementation in infants and children showed a 25-30% reduction in incidence and duration of acute and chronic diarrhea.
“Controlled trials of zinc supplementation in infants and children showed a 25-30% reduction in the incidence and duration of acute and chronic diarrhea and a reduction of up to 50% in the incidence of pneumonia (30 -32).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [30] Sazawal, 1995, Zinc supplementation in young children with acute diarrhea in India, N Engl J Med source
Not checked in the free run.
- cites [31] Sazawal, 1996, Zinc supplementation reduces the incidence of persistent diarrhea and dysentery among low socioeconomic children in India, J Nutr source
Not checked in the free run.
- cites [32] Sazawal, 1998, Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children—a double-blind controlled trial, Pediatrics source
Not checked in the free run.
- Premiseown data
In zinc-deficient persons, ex vivo generation of IL-1β is increased.
“We previously observed that, in zinc-deficient persons, ex vivo generation of IL-1 is increased, which suggests that zinc deficiency, per se, may activate monocytes and macrophages to generate inflammatory cytokines.”
Quote in the paperSubstantial claim - Premisecitation
Nearly 30-35% of the upper middle-class elderly population in the Detroit area may be zinc deficient, as judged by lymphocyte zinc concentrations.
“Results from our previous research indicate that nearly 30 -35% of the upper middle-class elderly population in the Detroit area may be zinc deficient, as judged by their lymphocyte zinc concentrations (37).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [37] Prasad, 1993, Zinc deficiency in elderly patients, Nutrition
Not checked in the free run.
- Premisecitation
In the authors' studies in patients with common cold, duration and severity of cold symptoms were about 50% less in zinc-treated subjects than in placebo group subjects.
“Although the effect of zinc on the common cold remains controversial, in our studies in patients with common cold, the duration and severity of cold symptoms were Ȃ50% less in zinc-treated subjects than in placebo group subjects (35).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Prasad, 2000, Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate, Ann Intern Med source
Not checked in the free run.
- Premisecitation
Oral zinc supplementation in zinc-deficient patients with sickle cell disease corrected ex vivo IL-2 generation.
“IL-2 production in zinc-deficient patients with sickle cell disease was low, and oral zinc supplementation (75 mg zinc as acetate) resulted in a decreased incidence of infections, fewer days in the hospitals, and correction of ex vivo IL-2 generation (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Prasad, 1999, Effects of zinc supplemntation on incidence of infections and hospital admissions in sickle cell disease (SCD), Am J Hematol source
Not checked in the free run.
- Interpretationcitation
The increase in IL-2 mRNA in zinc-deficient elderly subjects after zinc supplementation is consistent with previous reports in experimental human model studies and in cell culture studies in the HUT-78 cell line.
“We have presented evidence for a significant increase in IL-2 mRNA in zinc-deficient elderly subjects after zinc supplementation, a finding consistent with our previous reports in experimental human model studies and in cell culture studies in the HUT-78 cell line (19,39).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] Prasad, 2004, Anti-oxidant effect of zinc in humans, Free Rad Biol Med source
Not checked in the free run.
- cites [39] Beck, 1997, Changes in cytokines production and T cell subpopulations in experimentally induced zinc deficient humans, Am J Physiol
Not checked in the free run.
- Premisecitation
Oral zinc supplementation in zinc-deficient patients with sickle cell disease resulted in fewer days in hospitals.
“IL-2 production in zinc-deficient patients with sickle cell disease was low, and oral zinc supplementation (75 mg zinc as acetate) resulted in a decreased incidence of infections, fewer days in the hospitals, and correction of ex vivo IL-2 generation (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Prasad, 1999, Effects of zinc supplemntation on incidence of infections and hospital admissions in sickle cell disease (SCD), Am J Hematol source
Not checked in the free run.
- Premisecitation
Zinc plays an important role in maintaining the activity of a range of immune cells, including neutrophils, monocytes, macrophages, natural killer cells, and B and T cells.
“Zinc is crucial to the normal development of immune cells, and it plays an important role in maintaining the activity of a range of immune cells, including neutrophils, monocytes, macrophages, natural killer cells, and B and T cells.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Prasad, 2002, Zinc, infection and immune function
Not checked in the free run.
- Premisecitation
Zinc is crucial to normal development of immune cells.
“Zinc is crucial to the normal development of immune cells, and it plays an important role in maintaining the activity of a range of immune cells, including neutrophils, monocytes, macrophages, natural killer cells, and B and T cells.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Prasad, 2002, Zinc, infection and immune function
Not checked in the free run.
- Premisecitation
Zinc-deficient subjects have greater susceptibility to a variety of pathogens.
“Zinc-deficient subjects have a greater susceptibility to a variety of pathogens (36).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Prasad, 2002, Zinc, infection and immune function
Not checked in the free run.
- Premisecitation
Oral zinc supplementation (75 mg zinc as acetate) in zinc-deficient patients with sickle cell disease decreased incidence of infections.
“IL-2 production in zinc-deficient patients with sickle cell disease was low, and oral zinc supplementation (75 mg zinc as acetate) resulted in a decreased incidence of infections, fewer days in the hospitals, and correction of ex vivo IL-2 generation (34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Prasad, 1999, Effects of zinc supplemntation on incidence of infections and hospital admissions in sickle cell disease (SCD), Am J Hematol source
Not checked in the free run.
- Interpretationown data
Zinc is involved in increasing IL-2 production in zinc-deficient elderly subjects by increasing gene expression of IL-2.
“We conclude that zinc is involved in increasing IL-2 production in zinc-deficient elderly subjects by increasing the gene expression of IL-2.”
Quote in the paperSubstantial claim- Rests on an assumption: Ex vivo IL-2 mRNA expression in mononuclear cells reflects in vivo IL-2 production.
- Interpretationown data
Zinc is an effective antiinflammatory agent.
“Results from the current study show that elderly subjects are oxidatively stressed and that zinc is an effective antiinflammatory as well as an antioxidant agent.”
Quote in the paperSubstantial claim - Premisecitation
Zinc alone decreased the incidence of blindness due to age-related macular degeneration in 25% of these elderly subjects.
“Zinc alone has decreased the incidence of blindness due to age-related macular degeneration in 25% of these elderly subjects, and, most important, increased longevity has also been reported in those treated with zinc (41,42).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41] 2001, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8, Arch Ophthalmol source
Not checked in the free run.
- cites [42] Clemons, 2004, Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13, Arch Ophthalmol source
Not checked in the free run.
- Interpretationown data
Zinc is an effective antioxidant agent.
“Results from the current study show that elderly subjects are oxidatively stressed and that zinc is an effective antiinflammatory as well as an antioxidant agent.”
Quote in the paperSubstantial claim - Premisecitation
Increased longevity has been reported in elderly subjects treated with zinc.
“Zinc alone has decreased the incidence of blindness due to age-related macular degeneration in 25% of these elderly subjects, and, most important, increased longevity has also been reported in those treated with zinc (41,42).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [41] 2001, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8, Arch Ophthalmol source
Not checked in the free run.
- cites [42] Clemons, 2004, Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13, Arch Ophthalmol source
Not checked in the free run.
- Classified as probably not a substantial claim. 22
- May combine two claims. 11
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataPlasma NO concentration was nonsignificantly lower in zinc-supplemented than placebo elderly at 6 months.
“A nonsignificantly lower concentration of NO was observed in the zinc group at the end of 6 mo.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataEx vivo generation of IL-10 decreased nonsignificantly with time in zinc-supplemented elderly.
“Ex vivo generation of IL-10 decreased nonsignificantly with time in the zinc group.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataAt baseline, generated IL-10 concentration was higher in the zinc group than in the placebo group (P=0.015).
“The generated IL-10 concentration was, however, higher in the zinc group than in the placebo group (P ҃ 0.015) at baseline, the explanation for which is unclear.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataPersons caring for patients, drawing blood, or running laboratory analyses were blinded to treatment assignment.
“The persons caring for the patient, involved in drawing blood, or running laboratory analyses were blinded to the assignment.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductown dataElderly subjects were randomly assigned in pairs to zinc or placebo using envelopes.
“Elderly subjects were randomly assigned in pairs to the zincsupplemented or the placebo group with the use of envelopes that each contained 2 smaller envelopes (1 assigning a subject to zinc treatment and 1 assigning a subject to placebo).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe study planned 50 participants to have about 80% power to detect a halving of infection incidence, assuming SD 0.95 and two-sided P=0.05.
“We chose a sample size of 50 for the current study so that we could detect a 50% reduction in the incidence of infections in the zinc-supplemented group, with a SD of 0.95, a 2-sided P value of 0.05, and an approximate power of ͧ80%.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenThe nurse practitioner who evaluated subjects for infections was blinded to treatment assignment.
“The nurse-practitioner was blinded to the treatment assignment.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationReports indicate that older adults experience zinc deficiency and increased infection susceptibility from impaired cell-mediated immunity.
“Zinc deficiency and susceptibility to infections due to cell-mediated immune dysfunction have been reported to occur in the elderly (3,4).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] Cakman, 1997, Zinc supplementation reconstitutes the production of interferon-α by leukocytes from elderly persons, J Interferon Cytokine Res source
Not checked in the free run.
- cites [4] Prasad, 1993
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataIn the RT-PCR substudy, baseline plasma zinc was similar in the zinc and placebo arms (86.38 vs 88 μg/dL, P=0.35).
“The mean plasma zinc concentrations at baseline in the zinc and placebo groups were 86.38 Ȁ 3.6 and 88 Ȁ 0.82 g/dL, respectively (P ҃ 0.35).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll subjects provided written informed consent.
“All subjects provided written informed consent.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataAge, sex, and ethnicity were balanced at baseline across the zinc and placebo arms.
“Neither the ages of the 2 groups or the number of men and women participating in each group differed significantly.An equal number of African Americans and whites participated in the 2 groups.No other variables differed significantly between the groups.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationTrials of TNF neutralization in septic shock and of IL-1 receptor antagonist or TNF antibody in rheumatoid arthritis imply these cytokines matter in those diseases.
“TNF neutralization in the treatment of septic shock (13,14) and the use of IL-1 receptor antagonist (IL-1ra) and TNF antibody in the treatment of rheumatoid arthritis (15,16) suggest that these cytokines are important in the pathogenesis of the above disorders.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [13] Beutler, 1995, TNF, Immunity and inflammatory disease: lessons of the past decade, J Invest Med
Not checked in the free run.
- cites [14] Pennington, 1993, Therapy with antibody to tumor necrosis factor in sepsis, Clin Infect Dis source
Not checked in the free run.
- cites [15] Elliott, 1994, Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (CA2) versus placebo in rheumatoid arthritis, Lancet source
Not checked in the free run.
- cites [16] Opal, 2002, Impact of basic research on tomorrow's medicine: anti-inflammatory cytokines, Chest source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenWayne State University's Human Investigation Committee approved the protocol, which followed the 1983 revision of the Helsinki Declaration.
“The study protocol was approved by the Human Investigation Committee of Wayne State University and was in accord with the Helsinki Declaration as revised in 1983.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChronic inflammation has been linked to elevated cardiovascular death rates among older adults.
“In addition, chronic inflammatory processes have been implicated in high cardiovascular mortality in elderly subjects (11,12).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [11] Ward, 1995, Cytokines, inflammation, and autoimmune diseases, Hosp Pract source
Not checked in the free run.
- cites [12] Kunsch, 2004, Selective inhibition of endothelial and moncyte redox-sensitive genes by AG1–1067: a novel antioxidant and anti inflammatory agent, J Pharm Exp Ther source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOxidative stress contributes importantly to several age-related chronic diseases, including atherosclerosis, cancer, neurodegeneration, and immune disorders.
“Oxidative stress has been recognized as an important contributing factor in several chronic diseases attributed to aging, such as atherosclerosis and related cardiovascular disorders, mutagenesis and cancer, neurodegeneration, and immunologic disorders and even in the aging process itself (5).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Castro, 2001, Reactive oxygen species in human health and disease, Nutrition source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductcitationInfection diagnosis followed the long-term care facility practice guidelines for fever and infection evaluation.
“the practice guidelines for evaluation of fever and infections in long-term care facilities was used as our basis (26).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Bentley, 2000, Practice guideline for evaluation of fever and infection in long-term care facilities, Clin Infect Dis source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe senior-center participants were in better health than elderly nursing-home residents.
“Thus, the subjects from St Patrick's were healthier than elderly persons living in nursing homes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenLabcatal Laboratories verified and certified the capsules' zinc content.
“The zinc content of capsules was checked and certified by Labcatal Laboratories.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationHigher TNF-α and IL-1β have been linked to cutaneous leishmaniasis, and more lipid peroxidation products have been linked to zinc deficiency in children with chronic giardiasis.
“Increases in inflammatory cytokines TNF-␣ and IL-1 have been associated with cutaneous leishmaniasis (17), and increases in lipid peroxidation products were associated with zinc deficiency in children with chronic giardiasis (18).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [17] Kocyigit, 2002, Associations among plasma selenium, zinc, copper, and iron concentrations and immunoregulatory cytokine levels in patients with cutaneous leishmaniasis, Biol Trace Elem Res source
Not checked in the free run.
- cites [18] Demirci, 2003, Serum iron, zinc and copper levels and lipid peroxidation in children with chronic giardiasis, J Health Pop Nutr
Not checked in the free run.
May combine two claims.
PremisecitationNF-κB is involved in gene expression of TNF-α and IL-1β in human monocytes and macrophages and HL-60 cells, and the effect of zinc in inhibiting gene expression of TNF-α and IL-1β is cell specific.
“Nuclear factor-B is involved in the gene expression of TNF-␣ and IL-1 in monocytes and macrophages in humans and HL-60 cells, and the effect of zinc in inhibiting the gene expression of TNF-␣ and IL-1 is cell specific (20 -25).”
Quote in the paperNot a substantial claim0 of 6 sources checked- cites [20] Prasad, 2002, Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-κB activation, J Lab Clin Med source
Not checked in the free run.
- cites [21] Prasad, 2001, Zinc activates NF-κB in HUT-78 cells, J Lab Clin Med source
Not checked in the free run.
- cites [22] Krikos, 1992, Transcriptional activation of the tumor necrosis factor alpha-inducible zinc finger protein, A20, is mediated by κB elements, J Biol Chem source
Not checked in the free run.
- cites [23] Heyninck, 1999, The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-κB activation at the level of TRAF6, FEBS Lett source
Not checked in the free run.
- cites [24] Jaattela, 1996, A20 zinc finger protein inhibits TNF and IL-1 signaling, J Immunol source
Not checked in the free run.
- cites [25] Song, 1996, The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation, Proc Natl Acad Sci U S A source
Not checked in the free run.
May combine two claims.
PremisecitationIn HL-60 cells, zinc increases expression of A20 and binding of A20 transactivating factor to DNA, resulting in inhibition of induced NF-κB activation.
“We previously provided evidence that, in the promyelocytic leukemia cell line HL-60, which differentiates to the monocyte and macrophage phenotype in response to phorbol-12-myristate-13-acetate, zinc increases the expression of A20 and the binding of A20 transactivating factor to DNA, which results in the inhibition of induced nuclear factor-B activation (19).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Prasad, 2004, Anti-oxidant effect of zinc in humans, Free Rad Biol Med source
Not checked in the free run.
May combine two claims.
InterpretationreasoningProviding zinc to zinc-deficient subjects should improve host defense and increase resistance to pathogens by enhancing the immune response.
“Thus, the enhancing effect on the immune response of providing zinc should translate into improved host defense and increased resistance to pathogens in zinc-deficient subjects.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThe current study provides a link between zinc supplementation, increased IL-2 mRNA production, decreased incidence of infections, decreased generation of inflammatory cytokines, and decreased oxidative stress in elderly subjects.
“Thus, the current study provides an important link between zinc supplementation, increased IL-2 mRNA production, decreased incidence of infections, decreased generation of inflammatory cytokines, and decreased oxidative stress in the elderly subjects.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationLow thymulin activity and low IL-2 production have been reported in zinc-deficient elderly subjects.
“Low thymulin activity and low IL-2 production have been reported in zinc-deficient elderly subjects (36).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Prasad, 2002, Zinc, infection and immune function
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationZinc has several key roles relating to cell signaling, cell activation, gene expression, protein synthesis, and apoptosis.
“Zinc has several key roles relating to cell signaling, cell activation, gene expression, protein synthesis, and apoptosis (36).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [36] Prasad, 2002, Zinc, infection and immune function
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationOther investigators have observed that zinc supplementation to elderly subjects increased numbers of circulating T cells in association with improved delayed-type hypersensitivity reactions and immunoglobulin G antibody responses to tetanus toxoid.
“Other investigators have observed that zinc supplementation to elderly subjects increased the numbers of circulating T cells in association with improved delayed-type hypersensitivity reactions and immunoglobulin G antibody responses to tetanus toxoid (38).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Duchateau, 1981, Beneficial effects of oral zinc supplementation on the immune response of old people Am J Med
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationThe decrease in IL-10 production may increase IL-2 production.
“We have also observed a decrease in IL-10 production in zinc-supplemented elderly subjects, and this decrease may also have an effect of increasing IL-2 production (40).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40] Opal, 1998, Interleukin-10 potential benefits and possible risks in clinical infectious diseases, Clin Infect Dis source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataThe increase in TNF-α in the placebo group may be an effect of increasing age.
“We also observed in the placebo group that TNF-␣ increased with time, which suggests that this increase may be an effect of increasing age.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationA long-term, still ongoing trial has been conducted for the past 10 years in patients with age-related macular degeneration who received 80 mg elemental zinc as oxide and 2 mg Cu to prevent copper deficiency.
“A long-term, still ongoing trial has been conducted for the past 10 y in patients with age-related macular degeneration who received 80 mg elemental zinc as oxide and 2 mg Cu to prevent copper deficiency (41).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] 2001, A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8, Arch Ophthalmol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe number of subjects in the trial was small.
“The limitation of the current study is that the number of subjects in the trial was small.”
Quote in the paperNot a substantial claim
The paper relies on this without support.
Before this study, zinc had not been reported for managing oxidative stress in elderly people.
“The use of zinc in the management of oxidative stress in the elderly has not, however, been reported.”
The paper relies on this without support.
The elderly participants in the study are representative of the general elderly population.
“Our study showed that zinc supplementation administered to the elderly population resulted in a significant decrease in the incidence of infection.”
The paper relies on this without support.
Ex vivo IL-2 mRNA expression in mononuclear cells reflects in vivo IL-2 production.
“We conclude that zinc is involved in increasing IL-2 production in zinc-deficient elderly subjects by increasing the gene expression of IL-2.”
The paper relies on this without support.
Inflammatory cytokines generate oxidative stress.
“These inflammatory cytokines, in turn, are known to generate oxidative stress.”
The paper relies on this without support.
The plasma zinc criteria used by the authors validly classify elderly subjects as zinc-deficient.
“According to our plasma zinc criteria, Ȃ35% of the elderly subjects in the current study were considered zinc-deficient.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Zinc supplementation in elderly adults significantly reduces incidence of infection.
“In elderly adults, zinc supplementation significantly reduces the incidence of infection [194].”
From Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (2012) · cites this paper as [194]
The authors' studies showed that zinc deficiency may affect nearly 30%-40% of well-off healthy ambulatory elderly subjects in the Detroit area, who had decreased plasma zinc and increased plasma lipid peroxidation products and endothelial cell adhesion molecules compared with healthy zinc-sufficient younger adults.
“Our studies also showed that zinc deficiency may affect nearly 30%–40% of the well-off healthy ambulatory elderly subjects in the Detroit area (75, 76). In these subjects, decreased plasma zinc and increased plasma lipid peroxidation products and endothelial cell adhesion molecules compared with the healthy zinc-sufficient younger adults were observed.”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [76]
In the 12-month trial, oxidative stress biomarkers in plasma decreased significantly in the zinc group compared with placebo.
“Oxidative stress biomarkers in the plasma also decreased significantly in the zinc group compared with the placebo group (76).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [76]
Zinc deficiency and susceptibility to infections due to cell-mediated immune dysfunction have been reported to occur in the elderly.
“Zinc deficiency and susceptibility to infections due to cell-mediated immune dysfunction have been reported to occur in the elderly (75, 76).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [76]
In the authors' comparison, elderly subjects had lower plasma zinc and higher percentages of cells producing IL-1β and TNF-α and higher generated cytokines than younger subjects.
“A comparison of the baseline data between the younger subjects (ages 18–54, n = 31) and the elderly subjects showed that the plasma zinc was lower and the percentage of cells producing IL-1β and TNF-α and the generated cytokines were significantly higher in the elderly subjects (76).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [76]
In the 12-month trial, plasma zinc increased and ex vivo generation of TNF-α and IL-10 decreased significantly in the zinc group compared with placebo.
“The plasma zinc increased, and ex vivo generation of TNF-α and IL-10 decreased significantly in the zinc group compared with the placebo group (76).”
From Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease (2013) · cites this paper as [76]
An estimated 30-40% of elderly subjects in the Detroit, Michigan, area have mild to moderate zinc deficiency.
“It is estimated that 30-40% of elderly subjects in the Detroit, Michigan, area have mild to moderate zinc deficiency (7).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Baseline zinc comparison is called both significant and nonsignificant
MajorThe results say baseline plasma zinc did not differ significantly between the separate study's groups, whereas the Table 7 note calls the difference significant at P = 0.016.
“At baseline, the plasma zinc and IL-2 mRNA concentrations did not differ significantly between the zinc and placebo group subjects (Table 7).”
“Despite the random assignment of zinc-deficient subjects into zinc or placebo group, the plasma zinc concentration was significantly lower in the zinc group than in the placebo group (P ҃ 0.016).”
White participant counts differ between groups
MinorThe text says the two groups had equal numbers of white participants, but Table 1 lists 17 in the zinc group and 19 in the placebo group.
“An equal number of African Americans and whites participated in the 2 groups.”
“| White | 17 | 19 |”
E-selectin sample exceeds the reported study cohort
MinorTable 2 lists 69 older subjects for the E-selectin measurement, although the study reports complete data on only 49 participants. The text does not account for the additional subjects in that comparison.
“| Plasma E-selectin (ng/mL) | 32.2 Ȁ 13.1 (19) | 84.6 Ȁ 47.6 (69) | 0.001 |”
“One participant in the zinc group dropped out on day 2. We therefore had complete data on 49 participants.”
IL-2 interaction has conflicting P values
MinorThe results give P = 0.0001 for the IL-2 mRNA group-by-time interaction, but Table 7 gives P = 0.001 for that interaction.
“Group ҂ time interactions were significant for IL-2 mRNA (P ҃ 0.0001) and plasma zinc (P ҃ 0.0088) concentrations.”
“| Zinc group | 0.38 Ȁ 0.07 4 | 0.63 Ȁ 0.03 | 0.001 |”
Baseline zinc values disagree for the separate cohort
MinorFor the six-person groups in the separate study, the narrative reports baseline plasma zinc means of 86.38 and 88, while Table 7 reports 84.0 and 86.8.
“The mean plasma zinc concentrations at baseline in the zinc and placebo groups were 86.38 Ȁ 3.6 and 88 Ȁ 0.82 g/dL, respectively (P ҃ 0.35).”
“| Zinc group | 84.0 Ȁ 3.03 | 97.6 Ȁ 5.98 | 0.0088 | | Placebo group | 86.8 Ȁ 2.04 | 89.2 Ȁ 3.06 | |”
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. E., & Cohen, J. (1989) · Technometrics · doi:10.2307/1270020 · Cited by 99,588 · see citing works
Statistical power analysis for the behavioral sciences
Cohen, J. (1990) · Computers Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,406 · see citing works
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,385 · see citing works
(2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.10.1417 · Cited by 3,285 · see citing works
Opal, S. M., & DePalo, V. A. (2000) · Chest · doi:10.1378/chest.117.4.1162 · Cited by 1,752 · see citing works
Elliott, M. J., Maini, R. N., Feldmann, M., Kalden, J. R., Antoni, C., Smolen, J. S., Leeb, B., Breedveld, F. C., Macfarlane, J. D., Bijl, J. A., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90628-9 · Cited by 1,682 · see citing works
Zinc and immune function: the biological basis of altered resistance to infection
Shankar, A. H., & Prasad, A. S. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.2.447s · Cited by 1,606 · see citing works
Self-citationSyndrome of iron deficiency anemia, hepatosplenomegaly, hypogonadism, dwarfism, and geophagia
Prasad, A. S., Halsted, J. A., & Nadimi, M. (1961) · The American Journal of Medicine · doi:10.1016/0002-9343(61)90137-1 · Cited by 791 · see citing works
Self-citationPrasad, A. S., Miale, A., FARID, Z., Sandstead, H. H., & Schulert, A. R. (1963) · PubMed · Cited by 586 · see citing works
Self-citationSazawal, S., Black, R. E., Jalla, S., Mazumdar, S., Sinha, A., & Bhan, M. K. (1998) · Pediatrics · doi:10.1542/peds.102.1.1 · Cited by 543 · see citing works
Antioxidant effect of zinc in humans
Prasad, A. S., Bao, B., Beck, F. W. J., Kucuk, O., & Sarkar, F. H. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.07.007 · Cited by 520 · see citing works
Self-citationKrikos, A., Laherty, C. D., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37138-8 · Cited by 444 · see citing works
Song, H. Y., Rothe, M., & Goeddel, D. V. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6721 · Cited by 414 · see citing works
Zinc Supplementation in Young Children with Acute Diarrhea in India
Sazawal, S., Black, R. E., Bhan, M. K., Bhandari, N., Sinha, A., & Jalla, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331304 · Cited by 383 · see citing works
Reactive oxygen species in human health and disease
Castro, L., & Freeman, B. A. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00570-0 · Cited by 296 · see citing works
Berkow, R. L., Wang, D., Larrick, J. W., Dodson, R. W., & Howard, T. H. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.11.3783 · Cited by 295 · see citing works
Beneficial effects of oral zinc supplementation on the immune response of old people
Duchateau, J., Delepesse, G., Vrijens, R., & Collet, H. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90849-4 · Cited by 267 · see citing works
TNF, immunity and inflammatory disease: lessons of the past decade.
Beutler, B. (1995) · PubMed · Cited by 260 · see citing works
Zinc deficiency in elderly patients.
Prasad, A. S., Fitzgerald, J. T., Hess, J. W., Kaplan, J., Pelen, F., & Dardenne, M. (1993) · PubMed · Cited by 244 · see citing works
Self-citationA20 zinc finger protein inhibits TNF and IL-1 signaling
Jäättelä, M., Mouritzen, H., Elling, F., & Bastholm, L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1166 · Cited by 242 · see citing works
Prasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-4-200008150-00006 · Cited by 228 · see citing works
Self-citation(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.5.716 · Cited by 215 · see citing works
Heyninck, K., & Beyaert, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01645-7 · Cited by 169 · see citing works
Prasad, A. S. (1993) · Springer eBooks · doi:10.1007/978-1-4757-9444-1 · Cited by 166 · see citing works
Self-citationDavis, J. N., Kucuk, O., Djuric, Z., & Sarkar, F. H. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00535-4 · Cited by 150 · see citing works
(2002) · CABI Publishing eBooks · doi:10.1079/9780851995830.0000 · Cited by 149 · see citing works
Sazawal, S., Black, R. E., Bhan, M. K., Jalla, S., Bhandari, N., Sinha, A., & Majumdar, S. (1996) · The Journal of Nutrition · doi:10.1093/jn/126.2.443 · Cited by 146 · see citing works
Antioxidants: an integrative approach
Lachance, P. A., Nakat, Z., & Jeong, W.-S. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00636-0 · Cited by 140 · see citing works
Practice guideline for evaluation of fever and infection in long-term care facilities
Bentley, D. W., Bradley, S., High, K., Schoenbaum, S., Taler, G., & Yoshikawa, T. T. (2000) · Clinical Infectious Diseases · doi:10.1086/314013 · Cited by 137 · see citing works
Zinc supplementation reconstitutes the production of interferon-α by leukocytes from elderly persons
CAKMAN, I., KIRCHNER, H., & RINK, L. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.469 · Cited by 121 · see citing works
Interleukin-10 potential benefits and possible risks in clinical infectious diseases
Opal, S. M., Wherry, J. C., & Grint, P. (1998) · Clinical Infectious Diseases · doi:10.1086/515032 · Cited by 114 · see citing works
Zinc and selenium, site-specific versus general antioxidation
Bettger, W. J. (1993) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y93-108 · Cited by 103 · see citing works
Zinc activates NF-κB in HUT-78 cells
Prasad, A. S., Bao, B., Beck, F. W. J., & Sarkar, F. H. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.118108 · Cited by 94 · see citing works
Self-citationKunsch, C., Luchoomun, J., Grey, J. Y., Olliff, L. K., Saint, L. B., Arrendale, R. F., Wasserman, M. A., Saxena, U., & Medford, R. M. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.059733 · Cited by 66 · see citing works
Prasad, A. S., Bao, B., Beck, F. W. J., & Sarkar, F. H. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.127908 · Cited by 65 · see citing works
Self-citationPotentiation of Neutrophil Function by Recombinant DNA-Produced Interleukin 1a
Ozaki, Y., Ohashi, T., & Kume, S. (1987) · Journal of Leukocyte Biology · doi:10.1002/jlb.42.6.621 · Cited by 63 · see citing works
Serum iron, zinc and copper levels and lipid peroxidation in children with chronic giardiasis.
Demirci, M., Delibaş, N., Altuntaş, İ., Öktem, F., & Yönden, Z. (2003) · PubMed · Cited by 51 · see citing works
Friis, H., Ndhlovu, P., Mduluza, T., Kaondera, K., Sandström, B., Michaelsen, K., Vennervald, B., & Christensen, N. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600359 · Cited by 46 · see citing works
PRASAD, A. S., Miale, A., Farid, Z., Hh, S., & Schulert, A. R. (1990) · PubMed · Cited by 33 · see citing works
Self-citationKocyigit, A., Gur, S., Erel, O., & Gurel, M. S. (2002) · Biological Trace Element Research · doi:10.1385/bter:90:1-3:47 · Cited by 30 · see citing works
Nutrition and immune function.
Yaqoob, P., & Calder, P. C. (2003) · CABI Publishing eBooks · doi:10.1079/9780851996790.0349 · Cited by 28 · see citing works
Therapy with antibody to tumor necrosis factor in sepsis
Pennington, J. E. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.supplement_2.s515 · Cited by 26 · see citing works
Zinc, infection and immune function.
Prasad, A. S. (2002) · CABI Publishing eBooks · doi:10.1079/9780851995830.0193 · Cited by 17 · see citing works
Self-citationCytokines, inflammation, and autoimmune diseases
Ward, P. A. (1995) · Hospital Practice · doi:10.1080/21548331.1995.11443197 · Cited by 13 · see citing works
Prasad (1999) · doi:10.1002/(sici)1096-8652(199907)61:3
Self-citation
Flagged first, then by citations
3 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Castle, 1993, Lowering the temperature criterion improves detection of infections in nursing home residents, Aging Immunol Infect Dis, 4, 67
- Beck, 1997, Changes in cytokines production and T cell subpopulations in experimentally induced zinc deficient humans, Am J Physiol, E1002
Cited by
Sorted by citations
Advances in metal-induced oxidative stress and human disease
Jomová, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,226 · see citing works
Kambe, T., Tsuji, T., Hashimoto, A., & Itsumura, N. (2015) · Physiological Reviews · doi:10.1152/physrev.00035.2014 · Cited by 1,158 · see citing works
Biomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,147 · see citing works
Zinc and human health: an update
Chasapis, C. T., Loutsidou, A. K., Spiliopoulou, C., & Stefanidou, M. E. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0775-1 · Cited by 1,072 · see citing works
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomová, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,028 · see citing works
Discovery of Human Zinc Deficiency: Its Impact on Human Health and Disease
Prasad, A. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003210 · Cited by 919 · see citing works
Self-citationZinc in Human Health: Effect of Zinc on Immune Cells
Prasad, A. S. (2008) · Molecular Medicine · doi:10.2119/2008-00033.prasad · Cited by 940 · see citing works
Self-citationZinc in Infection and Inflammation
Gammoh, N. Z., & Rink, L. (2017) · Nutrients · doi:10.3390/nu9060624 · Cited by 829 · see citing works
Zinc as a Gatekeeper of Immune Function
Weßels, I., Maywald, M., & Rink, L. (2017) · Nutrients · doi:10.3390/nu9121286 · Cited by 780 · see citing works
The Role of Zinc in Antiviral Immunity
Read, S. A., Obeid, S., Ahlenstiel, C., & Ahlenstiel, G. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz013 · Cited by 754 · see citing works
Biomarkers of Nutrition for Development (BOND)—Zinc Review
King, J. C., Brown, K. H., Gibson, R. S., Krebs, N. F., Lowe, N. M., Siekmann, J. H., & Raiten, D. J. (2016) · Journal of Nutrition · doi:10.3945/jn.115.220079 · Cited by 581 · see citing works
Zinc: role in immunity, oxidative stress and chronic inflammation
Prasad, A. S. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3283312956 · Cited by 553 · see citing works
Self-citationZinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health
Prasad, A. S. (2014) · Frontiers in Nutrition · doi:10.3389/fnut.2014.00014 · Cited by 514 · see citing works
Self-citationNutritional Modulation of Immune Function: Analysis of Evidence, Mechanisms, and Clinical Relevance
Wu, D., Lewis, E. D., Pae, M., & Meydani, S. N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03160 · Cited by 494 · see citing works
Nutritional considerations for healthy aging and reduction in age-related chronic disease
Shlisky, J., Bloom, D. E., Beaudreault, A. R., Tucker, K. L., Keller, H. H., Freund-Levi, Y., Fielding, R. A., Cheng, F. W., Jensen, G. L., Wu, D., et al. (2017) · Advances in Nutrition · doi:10.3945/an.116.013474 · Cited by 462 · see citing works
Clinical, immunological, anti-inflammatory and antioxidant roles of zinc
Prasad, A. S. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2007.10.013 · Cited by 454 · see citing works
Self-citationZinc and diabetes — clinical links and molecular mechanisms
Jansen, J., Karges, W., & Rink, L. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.009 · Cited by 443 · see citing works
Zinc deficiency and cellular oxidative stress: Prognostic implications in cardiovascular diseases
Choi, S., Liu, X., & Pan, Z. (2018) · Acta Pharmacologica Sinica · doi:10.1038/aps.2018.25 · Cited by 397 · see citing works
Bao, B., Prasad, A. S., Beck, F. W., Fitzgerald, J. T., Snell, D., Bao, G. W., Singh, T., & Cardozo, L. J. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28836 · Cited by 400 · see citing works
Self-citationLorena Porte, T., Legarraga, P., Vollrath, V., Aguilera, X., Munita, J. M., Rafael Araos, B., Pizarro, G., Vial, P., Iruretagoyena, M., Dittrich, S., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.05.098 · Cited by 371 · see citing works
A Guide to Human Zinc Absorption: General Overview and Recent Advances of In Vitro Intestinal Models
Maares, M., & Haase, H. (2020) · Nutrients · doi:10.3390/nu12030762 · Cited by 377 · see citing works
ZIP8 Regulates Host Defense through Zinc-Mediated Inhibition of NF-κB
Liu, M.-J., Bao, S., Gálvez-Peralta, M., Pyle, C. J., Rudawsky, A. C., Pavlovicz, R. E., Killilea, D. W., Li, C., Nebert, D. W., Wewers, M. D., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.01.009 · Cited by 367 · see citing works
Estresse oxidativo: conceito, implicações e fatores modulatórios
Barbosa, K. B. F., Costa, N. M. B., Alfenas, R. D. C. G., de Paula, S. O., Minim, V. P. R., & Bressan, J. (2010) · Revista de Nutrição · doi:10.1590/s1415-52732010000400013 · Cited by 357 · see citing works
Discovery of human zinc deficiency: 50 years later
Prasad, A. S. (2012) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2012.04.004 · Cited by 336 · see citing works
Self-citationThe Potential Impact of Zinc Supplementation on COVID-19 Pathogenesis
Weßels, I., Rolles, B., & Rink, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01712 · Cited by 340 · see citing works
The immune system and the impact of zinc during aging
Haase, H., & Rink, L. (2009) · Immunity & Ageing · doi:10.1186/1742-4933-6-9 · Cited by 334 · see citing works
The Role of Minerals in the Optimal Functioning of the Immune System
Weyh, C., Krüger, K., Peeling, P., & Castell, L. M. (2022) · Nutrients · doi:10.3390/nu14030644 · Cited by 349 · see citing works
Impact of the Discovery of Human Zinc Deficiency on Health
Prasad, A. S. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719780 · Cited by 320 · see citing works
Self-citationZinc: Mechanisms of Host Defense1,
Prasad, A. S. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.5.1345 · Cited by 314 · see citing works
Self-citationZinc signals and immune function
Haase, H., & Rink, L. (2013) · BioFactors · doi:10.1002/biof.1114 · Cited by 305 · see citing works
Zinc: An antioxidant and anti-inflammatory agent: Role of zinc in degenerative disorders of aging
Prasad, A. S. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.07.019 · Cited by 295 · see citing works
Self-citationZinc and Regulation of Inflammatory Cytokines: Implications for Cardiometabolic Disease
Foster, M. J., & Samman, S. (2012) · Nutrients · doi:10.3390/nu4070676 · Cited by 281 · see citing works
Zinc: an essential micronutrient.
Saper, R. B., & Rash, R. (2009) · PubMed · Cited by 260 · see citing works
Molecular Mechanisms of Zinc as a Pro-Antioxidant Mediator: Clinical Therapeutic Implications
Prasad, A. S., & Bao, B. (2019) · Antioxidants · doi:10.3390/antiox8060164 · Cited by 256 · see citing works
Self-citationCurrent understanding of ZIP and ZnT zinc transporters in human health and diseases
Kambe, T., Hashimoto, A., & Fujimoto, S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1617-0 · Cited by 247 · see citing works
The Role of Micronutrients in Support of the Immune Response against Viral Infections
Pecora, F., Persico, F., Argentiero, A., Neglia, C., & Esposito, S. (2020) · Nutrients · doi:10.3390/nu12103198 · Cited by 270 · see citing works
Zinc Essentiality, Toxicity, and Its Bacterial Bioremediation: A Comprehensive Insight
Hussain, S., Khan, M., Sheikh, T. M. M., Mumtaz, M. Z., Chohan, T. A., Shamim, S., & Liu, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.900740 · Cited by 250 · see citing works
The redox biology of redox-inert zinc ions
Maret, W. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.006 · Cited by 237 · see citing works
Tuerk, M. J., & Fazel, N. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328321b395 · Cited by 237 · see citing works
The Th17/Treg balance is disturbed during aging
Schmitt, V., Rink, L., & Uciechowski, P. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.09.003 · Cited by 235 · see citing works
Prasad, A. S., Beck, F. W. J., Snell, D. C., & Kucuk, O. (2009) · Nutrition and Cancer · doi:10.1080/01635580903285122 · Cited by 218 · see citing works
Self-citationThe Oxidative Stress of Zinc Deficiency
Eide, D. J. (2011) · Metallomics · doi:10.1039/c1mt00064k · Cited by 214 · see citing works
Dietary and Physiological Effects of Zinc on the Immune System
Weßels, I., Fischer, H. J., & Rink, L. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-122019-120635 · Cited by 207 · see citing works
Zinc: Dietary intake and impact of supplementation on immune function in elderly
Mocchegiani, E., Romeo, J., Malavolta, M., Costarelli, L., Giacconi, R., Diaz, L.-E., & Marcos, A. (2013) · AGE · doi:10.1007/s11357-011-9377-3 · Cited by 198 · see citing works
Derwand, R., & Scholz, M. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109815 · Cited by 192 · see citing works
Besecker, B. Y., Exline, M. C., Hollyfield, J. L., Phillips, G. S., DiSilvestro, R. A., Wewers, M. D., & Knoell, D. L. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.008417 · Cited by 191 · see citing works
Bao, B., Prasad, A. S., Beck, F. W. J., Snell, D., Suneja, A., Sarkar, F. H., Doshi, N., Fitzgerald, J. T., & Swerdlow, P. (2008) · Translational Research · doi:10.1016/j.trsl.2008.06.001 · Cited by 187 · see citing works
Self-citationInteractions of zinc- and redox-signaling pathways
Hübner, C., & Haase, H. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101916 · Cited by 183 · see citing works
Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition of nuclear factor-κB
Prasad, A. S., Bao, B., Beck, F. W. J., & Sarkar, F. H. (2011) · Nutrition · doi:10.1016/j.nut.2010.08.010 · Cited by 182 · see citing works
Self-citationRondanelli, M., Miccono, A., Lamburghini, S., Avanzato, I., Riva, A., Allegrini, P., Faliva, M. A., Peroni, G., Nichetti, M., & Perna, S. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/5813095 · Cited by 185 · see citing works
Impact of the discovery of human zinc deficiency on health
Prasad, A. S. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.09.002 · Cited by 184 · see citing works
Self-citationHorowitz, R. I., Freeman, P. R., & Bruzzese, J. (2020) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2020.101063 · Cited by 181 · see citing works
The role of nutrition in enhancing immunity in aging.
Pae, M., Meydani, S. N., & Wu, D. (2012) · Europe PMC (PubMed Central) · Cited by 173 · see citing works
Alam, S., & Kelleher, S. L. (2012) · Nutrients · doi:10.3390/nu4080875 · Cited by 163 · see citing works
McCarty, M. F., & DiNicolantonio, J. J. (2020) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2020.02.007 · Cited by 163 · see citing works
Dietary zinc and iron intake and risk of depression: a meta-analysis
Li, Z., Li, B., Song, X., & Zhang, D. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.02.006 · Cited by 156 · see citing works
Serum zinc and pneumonia in nursing home elderly
Meydani, S. N., Barnett, J. B., Dallal, G. E., Fine, B. C., Jacques, P. F., Leka, L. S., & Hamer, D. H. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.1167 · Cited by 155 · see citing works
Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity
Cassat, J. E., & Skaar, E. P. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0294-4 · Cited by 155 · see citing works
Molnar, J. A., Underdown, M. J., & Clark, W. A. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0530 · Cited by 151 · see citing works
Zinc deficiency increases organ damage and mortality in a murine model of polymicrobial sepsis*
Knoell, D. L., JULIAN, M. W., Bao, S., Besecker, B. Y., Macre, J. E., Leikauf, G. D., DiSilvestro, R. A., & Crouser, E. D. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819cefe4 · Cited by 150 · see citing works
Weßels, I., Haase, H., Engelhardt, G., Rink, L., & Uciechowski, P. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.06.007 · Cited by 147 · see citing works
Zinc and Redox Signaling: Perturbations Associated with Cardiovascular Disease and Diabetes Mellitus
Foster, M. J., & Samman, S. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3111 · Cited by 149 · see citing works
Low zinc status: a new risk factor for pneumonia in the elderly?
Barnett, J. B., Hamer, D. H., & Meydani, S. N. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00253.x · Cited by 149 · see citing works
Barnett, J. B., Dao, M. C., Hamer, D. H., Kandel, R., Brandeis, G. H., Wu, D., Dallal, G. E., Jacques, P. F., Schreiber, R., Kong, E., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.115188 · Cited by 148 · see citing works
The Role of Oxidative Stress in Amyotrophic Lateral Sclerosis and Parkinson’s Disease
Baillet, A. C., Chanteperdrix, V., Trocmé, C., Casez, P., Garrel, C., & Besson, G. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0212-5 · Cited by 143 · see citing works
The ubiquitous role of zinc in health and disease
Cummings, J. E., & Kovacic, J. P. (2009) · Journal of Veterinary Emergency and Critical Care · doi:10.1111/j.1476-4431.2009.00418.x · Cited by 142 · see citing works
Mechanisms underlying the health effects of desert sand dust
Fussell, J. C., & Kelly, F. J. (2021) · Environment International · doi:10.1016/j.envint.2021.106790 · Cited by 140 · see citing works
Differential Regulation of TLR-Dependent MyD88 and TRIF Signaling Pathways by Free Zinc Ions
Brieger, A., Rink, L., & Haase, H. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301261 · Cited by 139 · see citing works
Gene expression profiling in sepsis: timing, tissue, and translational considerations
Maslove, D. M., & Wong, H. R. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.006 · Cited by 130 · see citing works
Dietary Supplements and Nutraceuticals under Investigation for COVID-19 Prevention and Treatment
Lordan, R., Rando, H. M., & Greene, C. S. (2021) · mSystems · doi:10.1128/msystems.00122-21 · Cited by 130 · see citing works
The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases
Wan, Y., & Zhang, B. (2022) · Biomolecules · doi:10.3390/biom12070900 · Cited by 128 · see citing works
Role of divalent metals in infectious disease susceptibility and outcome
Weiss, G., & Carver, P. L. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.018 · Cited by 123 · see citing works
Calder, P. C., Ortega, E. F., Meydani, S. N., Adkins, Y. C., Stephensen, C. B., Thompson, B., & Zwickey, H. L. (2022) · Advances in Nutrition · doi:10.1093/advances/nmac052 · Cited by 136 · see citing works
Kahmann, L., Uciechowski, P., Warmuth, S., Plümäkers, B., Gressner, A. M., Malavolta, M., Mocchegiani, E., & Rink, L. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0613 · Cited by 124 · see citing works
Jansen, J., Rosenkranz, E., Overbeck, S., Warmuth, S., Mocchegiani, E., Giacconi, R., Weiskirchen, R., Karges, W., & Rink, L. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.09.008 · Cited by 123 · see citing works
Prasad, A. S., Beck, F. W. J., Bao, B., Snell, D., & Fitzgerald, J. T. (2008) · The Journal of Infectious Diseases · doi:10.1086/528803 · Cited by 121 · see citing works
Self-citationZinc Competition among the Intestinal Microbiota
Gielda, L. M., & DiRita, V. J. (2012) · mBio · doi:10.1128/mbio.00171-12 · Cited by 121 · see citing works
Wilson, R. L., Grieger, J. A., Bianco‐Miotto, T., & Roberts, C. T. (2016) · Nutrients · doi:10.3390/nu8100641 · Cited by 120 · see citing works
Maret, W. (2013) · Metal ions in life sciences · doi:10.1007/978-94-007-7500-8_12 · Cited by 121 · see citing works
Zinc and its role in age‐related inflammation and immune dysfunction
Wong, C. P., & Ho, E. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100511 · Cited by 113 · see citing works
T-Lymphocytes: A Target for Stimulatory and Inhibitory Effects of Zinc Ions
Hönscheid, A., Rink, L., & Haase, H. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009788452390 · Cited by 107 · see citing works
Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
Vogel-González, M., Talló-Parra, M., Herrera-Fernández, V., Pérez‐Vilaró, G., Chillón, M., Nogués, X., Gómez-Zorrilla, S., López-Montesinos, I., Villar-García, J., Sorlí, L., et al. (2021) · Nutrients · doi:10.3390/nu13020562 · Cited by 110 · see citing works
Derwand, R., Scholz, M., & Zelenko, V. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106214 · Cited by 111 · see citing works
COVID-19 Pandemic: Can Maintaining Optimal Zinc Balance Enhance Host Resistance?
Razzaque, M. S. (2020) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.251.175 · Cited by 105 · see citing works
Joe, A., Park, S.-H., Kim, D.-J., Lee, Y.-J., Jhee, K.-H., Sohn, Y., & Jang, E. (2018) · Journal of Solid State Chemistry · doi:10.1016/j.jssc.2018.08.003 · Cited by 101 · see citing works
Behavioral impairments in animal models for zinc deficiency
Hagmeyer, S., Haderspeck, J., & Grabrucker, A. M. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00443 · Cited by 98 · see citing works
Wong, C. P., Magnusson, K. R., & Ho, E. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.07.005 · Cited by 98 · see citing works
Zinc, aging, and immunosenescence: an overview
Cabrera, Á. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.25592 · Cited by 100 · see citing works
Zinc homeostasis and immunosenescence
Maywald, M., & Rink, L. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.06.003 · Cited by 98 · see citing works
Seet, R. C. S., Lee, J. C., Lim, E. C. H., Quek, A. M. L., Huang, H.-W., Huang, S. H., Looi, W. F., Long, L. H., & Halliwell, B. B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.097 · Cited by 95 · see citing works
Ranjbar, E., Shams, J., Sabetkasaei, M., M-Shirazi, M., Rashidkhani, B., Mostafavi, A., Bornak, E., & Nasrollahzadeh, J. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000066 · Cited by 92 · see citing works
Chen, B., Jianguo, S., Zhang, X., Pan, F., Yang, X., & Feng, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106826 · Cited by 92 · see citing works
Salazar, G., Huang, J., Feresin, R. G., Zhao, Y., & Griendling, K. K. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.03.032 · Cited by 92 · see citing works
Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes
Mocchegiani, E., Giacconi, R., & Malavolta, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.08.002 · Cited by 91 · see citing works
Alker, W., & Haase, H. (2018) · Nutrients · doi:10.3390/nu10080976 · Cited by 95 · see citing works
Zinc: An element of extensive medical importance
Wani, A. L., Parveen, N., Ansari, M. O., Ahmad, M. F., Jameel, S., & Shadab, G. G. H. A. (2017) · Current Medicine Research and Practice · doi:10.1016/j.cmrp.2017.02.006 · Cited by 88 · see citing works
Zinc Intakes and Health Outcomes: An Umbrella Review
Li, J. H., Cao, D., Huang, Y. C., Chen, B., Chen, Z., Wang, R., Dong, Q. G., Wei, Q., & Liu, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.798078 · Cited by 91 · see citing works
Costarelli, L., Muti, E., Malavolta, M., Cipriano, C., Giacconi, R., Tesei, S., Piacenza, F., Pierpaoli, S., Gasparini, N., Faloia, E., et al. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.02.001 · Cited by 85 · see citing works
Mocchegiani, E., Costarelli, L., Giacconi, R., Malavolta, M., Basso, A., Piacenza, F., Ostan, R., Cevenini, E., Gonos, E. S., & Monti, D. (2014) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.12.007 · Cited by 85 · see citing works
Siddique, K., Ashfaq, F., Ali, W., Reddy, H., Mishra, A., & Khan, M. I. (2013) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.117002 · Cited by 82 · see citing works
- Authors
- Prasad, A. S., Beck, F. W., Bao, B., Fitzgerald, J. T., Snell, D. C., Steinberg, J. D., & Cardozo, L. J.
- Affiliations
- Wayne State University (US)
- Corresponding author
- Prasad, Ananda S
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 85
- Issue
- 3
- Pages
- 837-844
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W1925247835
- Semantic Scholar
- 11116558de00f3cc34601cbec8e847680dbab8ce
- Cited by
- 516
- References
- 48
- Citations by year
- 2026: 14 · 2025: 12 · 2024: 30 · 2023: 24 · 2022: 42 · 2021: 58 · 2020: 50 · 2019: 24 · 2018: 24 · 2017: 28 · 2016: 14 · 2015: 22 · 2014: 31 · 2013: 25 · 2012: 25
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- U.S. Public Health Service (5 R01 A150698-04)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Rehabilitation › Exercise and Physiological Responses
- Keywords
- zinc supplementation, zinc deficiency, older adults, infection incidence, cytokines, oxidative stress, TNF-α, IL-10, interleukin-2, T helper cells, plasma zinc, endothelial adhesion molecules, zinc gluconate, immune function
- MeSH terms
- Adolescent, Adult, Aged, Double-Blind Method, Female, Humans, Infections, Male, Middle Aged, Zinc, Incidence, Cytokines, Oxidative Stress, Th1 Cells, Th2 Cells, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review